Company performance
Add to research
Current Price
as of Mar 20, 2025$38.49
P/E Ratio
N/A
Market Cap
$7.09B
Description
Add to research
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Metrics
Add to research
Overview
- HQRedwood City, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Other
- TickerRVMD
- Price$38.49-0.67%
Trading Information
- Market cap$7.09B
- Float86.98%
- Average Daily Volume (1m)1,460,083
- Average Daily Volume (3m)1,300,862
- EPS-$3.58
Company
- RevenueN/A
- Rev growth (1yr)-100.00%
- Net income-$600.09M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$677.70M
- EV$5.18B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B3.16
- Debt/Equity6.00
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account